We are applying our expertise and experience with designing, developing, and evaluating novel RNA therapeutics to the address the urgent needs of the COVID-19 pandemic. Our lab is providing all needed support as HMRI’s RNA Core develops an mRNA-based COVID-19 vaccine. – Press Release PDF

Dr. Kiss featured postdoctoral fellow alumni, Pelotonia  – PDF

Dr. Kiss is awarded a Career Development Award titled “Construction of circular RNAs to block miRNA-driven oncogenic transformation” from The American Society for Gene and Cell Therapy. – LINK

Dr. Kiss, live-streamed Journal club:

The Kiss RNA Lab’s first paper is featured as an Editor’s Choice paper by the editors of FEBS Letters. – LINK